Literature DB >> 24684571

New physiopathological and therapeutic approaches to diverticular disease: an update.

Antonio Tursi1.   

Abstract

INTRODUCTION: Diverticular disease (DD) of the colon is a widespread disease, which shows worldwide increasing incidence and represents a significant burden for National Health Systems. The current guidelines claim that symptomatic uncomplicated DD (SUDD) has to be treated with spasmolithics and high-fiber diet, whereas both uncomplicated and complicated acute diverticulitis has to be treated with antibiotics. However, new physiopathological knowledge suggests that further treatment may be promising. AREAS COVERED: Pathogenetic and treatment studies on SUDD and acute diverticulitis published in PubMed, www.clinicaltrials.gov , and in the main International Congress were reviewed. EXPERT OPINION: Although absorbable antibiotics and 5-aminosalycilic acid seem to be effective in treating SUDD, their role in preventing diverticulitis recurrence is still under debate. Antibiotic use in managing acute diverticulitis is at least questionable, and use of probiotics seems to be promising but need further robust studies to confirm the preliminary results.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24684571     DOI: 10.1517/14656566.2014.903922

Source DB:  PubMed          Journal:  Expert Opin Pharmacother        ISSN: 1465-6566            Impact factor:   3.889


  7 in total

1.  Predictive value of the Diverticular Inflammation and Complication Assessment (DICA) endoscopic classification on the outcome of diverticular disease of the colon: An international study.

Authors:  Antonio Tursi; Giovanni Brandimarte; Francesco Di Mario; Maria L Annunziata; Mauro Bafutto; Maria A Bianco; Raffaele Colucci; Rita Conigliaro; Silvio Danese; Rudi De Bastiani; Walter Elisei; Ricardo Escalante; Roberto Faggiani; Luciano Ferrini; Giacomo Forti; Giovanni Latella; Maria G Graziani; Enio C Oliveira; Alfredo Papa; Antonio Penna; Piero Portincasa; Kjetil Søreide; Antonio Spadaccini; Paolo Usai; Stefanos Bonovas; Carmelo Scarpignato; Marcello Picchio; Piera G Lecca; Costantino Zampaletta; Claudio Cassieri; Alberto Damiani; Kari F Desserud; Serafina Fiorella; Rosario Landi; Elisabetta Goni; Maria A Lai; Flavia Pigò; Gianluca Rotondano; Giuseppe Schiaccianoce
Journal:  United European Gastroenterol J       Date:  2015-11-13       Impact factor: 4.623

2.  Effect of oral mesalamine on inflammatory response in acute uncomplicated diverticulitis.

Authors:  Luca Nespoli; Giulia Lo Bianco; Fabio Uggeri; Fabrizio Romano; Angelo Nespoli; Davide Paolo Bernasconi; Luca Gianotti
Journal:  World J Gastroenterol       Date:  2015-07-21       Impact factor: 5.742

3.  Factors Associated with Repeated Health Resource Utilization in Patients with Diverticulitis.

Authors:  Steven N Mathews; Ryan Lamm; Jie Yang; Lijuan Kang; Dana Telem; Aurora D Pryor; Mark Talamini; Jill Genua
Journal:  J Gastrointest Surg       Date:  2016-09-09       Impact factor: 3.452

Review 4.  Pathophysiology and Therapeutic Strategies for Symptomatic Uncomplicated Diverticular Disease of the Colon.

Authors:  Eleonora Scaioli; Antonio Colecchia; Giovanni Marasco; Ramona Schiumerini; Davide Festi
Journal:  Dig Dis Sci       Date:  2015-10-12       Impact factor: 3.199

Review 5.  Recent advances in the treatment of colonic diverticular disease and prevention of acute diverticulitis.

Authors:  Walter Elisei; Antonio Tursi
Journal:  Ann Gastroenterol       Date:  2016 Jan-Mar

6.  Symptomatic uncomplicated diverticular disease management: an innovative food-grade formulation of Curcuma longa and Boswellia serrata extracts.

Authors:  Attilio Giacosa; Antonella Riva; Giovanna Petrangolini; Pietro Allegrini; Teresa Fazia; Luisa Bernardinelli; Clara Gasparri; Milena Anna Faliva; Gabriella Peroni; Simone Perna; Mariangela Rondanelli
Journal:  Drugs Context       Date:  2020-12-14

Review 7.  Lactobacillus paracasei CNCM I 1572: A Promising Candidate for Management of Colonic Diverticular Disease.

Authors:  Elisabetta Bretto; Ferdinando D'Amico; Walter Fiore; Antonio Tursi; Silvio Danese
Journal:  J Clin Med       Date:  2022-03-30       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.